Endocrine News speaks with Rebecca Reynolds, MD, PhD, the Endocrine Society’s 2026 International Excellence in Endocrinology Laureate Award, about why so much of women’s health begins in pregnancy as well as the many unanswered questions about fetal growth. The earliest stages of life can shape health for decades, and Rebecca Reynolds, MD, PhD, has dedicated her career to understanding why.
Her discoveries have transformed how scientists and clinicians view pregnancy and metabolic health, and in recognition of her groundbreaking contributions, the Endocrine Society has named her one of its distinguished 2026 Laureates and awarded her the International Excellence Award. Reynolds serves as Personal Chair of Metabolic Medicine and Dean International at the University of Edinburgh’s College of Medicine and Veterinary Medicine.
Her research has transformed our understanding of how endocrine pathways influence both maternal and child health. By uncovering the cardiometabolic risks associated with obesity in pregnancy, she has not only advanced scientific knowledge but also translated those discoveries into clinical trials and practical therapies — directly improving outcomes for mothers and babies.
Her impact extends far beyond the laboratory.
Endocrine News published a clinical update in Research Highlights on 13 Mar 2026.
The item focuses on Stress Test: How Pregnancy Could Be a Risk Indicator for Both Mother and Child.
Review the original article for the full source wording and details.